Cargando…
Tail-Approach-Based Design and Synthesis of Coumarin-Monoterpenes as Carbonic Anhydrase Inhibitors and Anticancer Agents
[Image: see text] In this study, sixty novel coumarin-monoterpene compounds were synthesized in two series [thirty-two compounds (12–43) bearing a triazole ring in the first series, and twenty-eight compounds (44–71) bearing an alkyl chain in the second one]. Their inhibitory effects on the human ca...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933483/ https://www.ncbi.nlm.nih.gov/pubmed/36816648 http://dx.doi.org/10.1021/acsomega.2c07459 |
_version_ | 1784889687576412160 |
---|---|
author | Zengin Kurt, Belma Celebi, Gulsen Ozturk Civelek, Dilek Angeli, Andrea Akdemir, Atilla Sonmez, Fatih Supuran, Claudiu T. |
author_facet | Zengin Kurt, Belma Celebi, Gulsen Ozturk Civelek, Dilek Angeli, Andrea Akdemir, Atilla Sonmez, Fatih Supuran, Claudiu T. |
author_sort | Zengin Kurt, Belma |
collection | PubMed |
description | [Image: see text] In this study, sixty novel coumarin-monoterpene compounds were synthesized in two series [thirty-two compounds (12–43) bearing a triazole ring in the first series, and twenty-eight compounds (44–71) bearing an alkyl chain in the second one]. Their inhibitory effects on the human carbonic anhydrase (hCA) isoforms I, II, IX, and XII and anticancer potentials were determined. All synthesized molecules selectively inhibited CA IX and XII. 23 and 42 were found to be the strongest inhibitors, with K(i) values of 1.9 nM against hCA IX. Also, 70 showed the highest inhibitory activity with a K(i) value of 4.9 nM against hCA XII. Moreover, their cytotoxic effects on colon adenocarcinoma (HT-29), prostate adenocarcinoma (PC-3), and breast adenocarcinoma (MCF-7) cell lines were evaluated. According to the cytotoxicity results, 14 (IC(50) = 2.48 μM) and 63 (IC(50) = 3.91 μM) exhibited the highest cytotoxicity on the MCF-7 cells, while 23 showed the strongest cytotoxic effect on both PC-3 (IC(50) = 9.40 μM) and HT-29 (IC(50) = 12.10 μM) cell lines. 14, 23, and 66 decreased CA IX and CA XII protein expression in HT-29 cells, while 23 and 66 showed the strongest reduction of both CA IX and CA XII in MCF-7 cells. All of the selected compounds increased total apoptosis in a concentration-dependent manner in HT-29 and MCF-7 cells. 14 has the strongest apoptotic effect in MCF-7 cells. 23 increased early apoptosis primarily, while 14 and 66 increased total apoptosis in HT-29. In addition, PI/Hoechst staining proves that apoptotic cells are increased in HT-29 with an effect of 14, 23, and 66. As a result of the modeling studies, it has been shown that only the open coumarin form of the compounds can interact directly with the active-site Zn(2+) ion. It has been shown that coumarin-monoterpene structures with different alkyl and monoterpene groups both specifically inhibit CA IX and XII and exhibit specific cytotoxicity in different cell lines. |
format | Online Article Text |
id | pubmed-9933483 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-99334832023-02-17 Tail-Approach-Based Design and Synthesis of Coumarin-Monoterpenes as Carbonic Anhydrase Inhibitors and Anticancer Agents Zengin Kurt, Belma Celebi, Gulsen Ozturk Civelek, Dilek Angeli, Andrea Akdemir, Atilla Sonmez, Fatih Supuran, Claudiu T. ACS Omega [Image: see text] In this study, sixty novel coumarin-monoterpene compounds were synthesized in two series [thirty-two compounds (12–43) bearing a triazole ring in the first series, and twenty-eight compounds (44–71) bearing an alkyl chain in the second one]. Their inhibitory effects on the human carbonic anhydrase (hCA) isoforms I, II, IX, and XII and anticancer potentials were determined. All synthesized molecules selectively inhibited CA IX and XII. 23 and 42 were found to be the strongest inhibitors, with K(i) values of 1.9 nM against hCA IX. Also, 70 showed the highest inhibitory activity with a K(i) value of 4.9 nM against hCA XII. Moreover, their cytotoxic effects on colon adenocarcinoma (HT-29), prostate adenocarcinoma (PC-3), and breast adenocarcinoma (MCF-7) cell lines were evaluated. According to the cytotoxicity results, 14 (IC(50) = 2.48 μM) and 63 (IC(50) = 3.91 μM) exhibited the highest cytotoxicity on the MCF-7 cells, while 23 showed the strongest cytotoxic effect on both PC-3 (IC(50) = 9.40 μM) and HT-29 (IC(50) = 12.10 μM) cell lines. 14, 23, and 66 decreased CA IX and CA XII protein expression in HT-29 cells, while 23 and 66 showed the strongest reduction of both CA IX and CA XII in MCF-7 cells. All of the selected compounds increased total apoptosis in a concentration-dependent manner in HT-29 and MCF-7 cells. 14 has the strongest apoptotic effect in MCF-7 cells. 23 increased early apoptosis primarily, while 14 and 66 increased total apoptosis in HT-29. In addition, PI/Hoechst staining proves that apoptotic cells are increased in HT-29 with an effect of 14, 23, and 66. As a result of the modeling studies, it has been shown that only the open coumarin form of the compounds can interact directly with the active-site Zn(2+) ion. It has been shown that coumarin-monoterpene structures with different alkyl and monoterpene groups both specifically inhibit CA IX and XII and exhibit specific cytotoxicity in different cell lines. American Chemical Society 2023-02-03 /pmc/articles/PMC9933483/ /pubmed/36816648 http://dx.doi.org/10.1021/acsomega.2c07459 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Zengin Kurt, Belma Celebi, Gulsen Ozturk Civelek, Dilek Angeli, Andrea Akdemir, Atilla Sonmez, Fatih Supuran, Claudiu T. Tail-Approach-Based Design and Synthesis of Coumarin-Monoterpenes as Carbonic Anhydrase Inhibitors and Anticancer Agents |
title | Tail-Approach-Based
Design and Synthesis of Coumarin-Monoterpenes
as Carbonic Anhydrase Inhibitors and Anticancer Agents |
title_full | Tail-Approach-Based
Design and Synthesis of Coumarin-Monoterpenes
as Carbonic Anhydrase Inhibitors and Anticancer Agents |
title_fullStr | Tail-Approach-Based
Design and Synthesis of Coumarin-Monoterpenes
as Carbonic Anhydrase Inhibitors and Anticancer Agents |
title_full_unstemmed | Tail-Approach-Based
Design and Synthesis of Coumarin-Monoterpenes
as Carbonic Anhydrase Inhibitors and Anticancer Agents |
title_short | Tail-Approach-Based
Design and Synthesis of Coumarin-Monoterpenes
as Carbonic Anhydrase Inhibitors and Anticancer Agents |
title_sort | tail-approach-based
design and synthesis of coumarin-monoterpenes
as carbonic anhydrase inhibitors and anticancer agents |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933483/ https://www.ncbi.nlm.nih.gov/pubmed/36816648 http://dx.doi.org/10.1021/acsomega.2c07459 |
work_keys_str_mv | AT zenginkurtbelma tailapproachbaseddesignandsynthesisofcoumarinmonoterpenesascarbonicanhydraseinhibitorsandanticanceragents AT celebigulsen tailapproachbaseddesignandsynthesisofcoumarinmonoterpenesascarbonicanhydraseinhibitorsandanticanceragents AT ozturkcivelekdilek tailapproachbaseddesignandsynthesisofcoumarinmonoterpenesascarbonicanhydraseinhibitorsandanticanceragents AT angeliandrea tailapproachbaseddesignandsynthesisofcoumarinmonoterpenesascarbonicanhydraseinhibitorsandanticanceragents AT akdemiratilla tailapproachbaseddesignandsynthesisofcoumarinmonoterpenesascarbonicanhydraseinhibitorsandanticanceragents AT sonmezfatih tailapproachbaseddesignandsynthesisofcoumarinmonoterpenesascarbonicanhydraseinhibitorsandanticanceragents AT supuranclaudiut tailapproachbaseddesignandsynthesisofcoumarinmonoterpenesascarbonicanhydraseinhibitorsandanticanceragents |